MP Materials Corp. — Q1 2023 Form 10-Q
Reporting period: Three months ended March 31, 2023. MP Materials operates the Mountain Pass rare earth mine and processing facility and reported one operating segment. It is transitioning from selling rare earth concentrate toward separated products and downstream metal, alloy, and magnet manufacturing.
Financial performance
| Metric | Q1 2023 | Q1 2022 | Change |
|---|---|---|---|
| Revenue | $95.7 million | $166.3 million | Down 42% |
| Operating income | $33.0 million | $115.0 million | Down 71% |
| Net income | $37.4 million | $85.6 million | Down 56% |
| Diluted EPS | $0.20 | $0.45 | Down |
| Adjusted EBITDA (non-GAAP) | $58.7 million | $132.3 million | Down 56% |
| Operating cash flow | $55.5 million | $121.0 million | Down 54% |
| Capital expenditures | $74.5 million | $54.9 million | Up |
| Free cash flow (non-GAAP) | $(19.0) million | $71.2 million | Lower |
Revenue fell primarily because realized price per REO metric ton declined 32% to $9,365 and sales volume declined 13% to 10,215 metric tons. Production was nearly flat at 10,671 metric tons, down 1%. Production cost per REO metric ton rose 24% to $1,978, principally due to higher payroll and, to a lesser extent, materials costs.
Operating costs and expenses increased 22% to $62.7 million. Advanced projects, start-up, development and other costs rose to $8.3 million, including Stage II commissioning expenses; depreciation, depletion and amortization increased to $8.1 million as new Stage II assets entered service. Net income included $13.7 million of other income, principally interest and investment income. The effective tax rate was 17.3%, versus 24.5%.
Financial position and liquidity
- Cash, cash equivalents and short-term investments totaled $1.169 billion at March 31, 2023, compared with $1.182 billion at year-end 2022. Cash and cash equivalents were $651.2 million; short-term investments were $517.8 million.
- Long-term debt, net, was $679.3 million, representing $690 million principal amount of 0.25% convertible notes due April 2026. Equipment notes totaled $6.5 million. The notes have no financial covenants disclosed in the filing.
- Current assets were $1.267 billion and current liabilities $93.9 million. Total liabilities were $929.3 million; stockholders’ equity was $1.352 billion.
- Investing cash flow was positive $462.2 million, largely reflecting short-term investment maturities and sales net of purchases, not operating cash generation. Cash, cash equivalents and restricted cash ended the quarter at $654.4 million.
Material developments, outlook and risks
- Management expects approximately $300 million of capital spending in 2023 for Stage II completion, early HREE Facility work, the Fort Worth Facility, and other growth and infrastructure investments. Further project costs are expected in 2024. Management said near-term resources are expected to fund plans, but cautioned that this cannot be assured and project costs or timing could increase.
- Stage II commissioning continued, with certain assets transferred into service. The company expects separated rare earth products, including NdPr oxide, after commissioning; the filing does not provide a clear date for reaching commercial run-rate production.
- The Fort Worth Facility is being built for rare earth metal, alloy and magnet production. A gradual production ramp under the GM supply agreement is expected to begin in late 2023, starting with alloy.
- New commercial arrangements include a February 2023 Sumitomo agreement for exclusive distribution of NdPr oxide to Japanese customers, and a March 2023 tolling agreement with VREX to process NdPr oxide into metal. No transactions under the VREX agreement had occurred by quarter-end.
- Customer concentration is significant: Shenghe accounted for more than 90% of product sales. The company’s concentrate offtake agreement with Shenghe is take-or-pay, but pricing is affected by realized sales prices in China and currency movements. Rare earth prices softened materially year over year.
- Key risks include commodity-price volatility, dependence on a limited number of refiners, China-related trade and policy uncertainty, Stage II/Stage III cost and schedule execution, supply-chain and shipping disruptions, and power, water, permitting, environmental, and labor risks. Management reported no material change to previously disclosed risk factors and no material pending or threatened litigation known to the company.
Management stated that cash resources and operating cash flows are expected to meet liquidity requirements for the foreseeable future, while warning that working-capital needs are expected to rise as the business transitions to separated products and expands downstream. The filing gives no formal revenue or earnings guidance.
Important facts for investors to verify
- Whether rare earth pricing and sales volumes stabilize, and how they affect realized prices and cash generation.
- Stage II commissioning progress, commercial production timing, and the resulting mix of concentrate versus separated-product sales.
- Whether the approximately $300 million 2023 capital-spending expectation and 2024 project work remain on budget and schedule.
- Progress toward the expected late-2023 GM alloy ramp and commercial activity under the Sumitomo and VREX agreements.
- Shenghe’s share of sales and any change in offtake terms, customer concentration, or exposure to China-related risks.
- How much operating cash flow is available after capital spending; Q1 free cash flow was negative $19.0 million despite positive operating cash flow.